DEXCOM INC (NASDAQ: DXCM)

DEXCOM INC

NASDAQ: DXCM (DexCom, Inc.)

Last update: 2 days ago, 10:49AM

58.31

-0.27 (-0.45%)

Add to watchlist

Previous Close	58.57
Open	59.02
Volume	929,251
Avg. Volume (3M)	4,463,093
Market Cap	22,498,324,480

Price / Earnings (TTM)	25.02
Price / Earnings (Forward)	23.47
Price / Sales	4.96
Price / Book	7.76

52 Weeks Range	54.11 (-7%) — 89.98 (54%)
Earnings Date	29 Jul 2026

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Mixed	Bearish
	Medical Devices (Global)	Mixed	Bearish
Stock	DexCom, Inc.	Bullish	Bearish

AIStockmoo Score

0.4

Analyst Consensus	5.0
Insider Activity	1.5
Price Volatility	0.5
Technical Moving Averages	-2.5
Technical Oscillators	-2.5
Average	0.40

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
DXCM	22 B	-	25.02	7.76
PODD	11 B	-	37.00	8.19
SSII	775 M	-	-	22.57
GEHC	28 B	0.23%	14.80	2.60
IRTC	4 B	-	-	24.29
TMDX	2 B	-	15.51	7.30

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Mid Growth
% Held by Insiders	0.42%
% Held by Institutions	97.10%

52 Weeks Range	54.11 (-7%) — 89.98 (54%)
Price Target Range	80.00 (37%) — 85.00 (45%)
High	85.00 (BTIG, 45.79%)	Buy
Median	84.00 (44.07%)
Low	80.00 (Truist Securities, 37.21%)	Buy
Average	83.00 (42.36%)
Total	3 Buy
Avg. Price @ Call	68.49

Firm	Date	Target Price	Call	Price @ Call
Citigroup	11 Mar 2026	84.00 (44.07%)	Buy	66.31
BTIG	09 Mar 2026	85.00 (45.79%)	Buy	68.74
BTIG	25 Feb 2026	85.00 (45.79%)	Buy	73.16
Truist Securities	17 Feb 2026	80.00 (37.21%)	Buy	70.43

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
ALTMAN STEVEN R	60.61	60.61	0	0
AUGUSTINOS NICHOLAS	60.61	60.61	0	0
COLLINS RICHARD ALEXANDER	60.61	60.61	0	0
FOLETTA MARK G	60.61	60.61	0	0
Aggregate Net Quantity				0
Aggregate Net Value ($)				0
Aggregate Avg. Buy ($)				60.61
Aggregate Avg. Sell ($)				60.61

Name	Holder	Date	Type	Quantity	Price	Value ($)
FOLETTA MARK G	Director	08 May 2026	Disposed (-)	5,731	60.61	347,356
FOLETTA MARK G	Director	08 May 2026	Acquired (+)	5,731	60.61	347,356
ALTMAN STEVEN R	Director	08 May 2026	Disposed (-)	5,037	60.61	305,293
ALTMAN STEVEN R	Director	08 May 2026	Acquired (+)	5,037	60.61	305,293
AUGUSTINOS NICHOLAS	Director	08 May 2026	Disposed (-)	5,046	60.61	305,838
AUGUSTINOS NICHOLAS	Director	08 May 2026	Acquired (+)	5,046	60.61	305,838
COLLINS RICHARD ALEXANDER	Director	08 May 2026	Disposed (-)	5,074	60.61	307,535
COLLINS RICHARD ALEXANDER	Director	08 May 2026	Acquired (+)	5,074	60.61	307,535

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	12.90%
Operating Margin (TTM)	12.91%
Diluted EPS (TTM)	1.33
Quarterly Revenue Growth (YOY)	12.50%
Quarterly Earnings Growth (YOY)	-28.00%

Total Debt/Equity (MRQ)	113.97%
Current Ratio (MRQ)	1.50
Operating Cash Flow (TTM)	964.10 M
Levered Free Cash Flow (TTM)	509.04 M

Return on Assets (TTM)	5.97%
Return on Equity (TTM)	23.72%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)